IA
CRMD icon

IFP Advisors’s CorMedix CRMD Stock Holding History

IFP Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9K Buy
3,807
+1,056
+38% +$8.34K ﹤0.01% 2726
2026
Q1 		$18.7K Buy
+2,751
New +$20.3K ﹤0.01% 2815
2025
Q3 		– Sell
-9
Closed -$677 – 4852
2025
Q2 		$677 Buy
+9
New +$99 ﹤0.01% 4343
2025
Q1 		– Sell
-5
Closed -$40 – 4384
2024
Q4 		$40 Buy
+5
New +$50 ﹤0.01% 4316

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

IFP Advisors's CRMD Position: Q2 2026 in Review

IFP Advisors increased its CorMedix (CRMD) stake by 38% in Q2 2026, buying an estimated $8.34K and bringing the position to 3,807 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2726.

IFP Advisors first reported a position in CRMD in Q4 2024 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • IFP Advisors held 3,807 shares of CorMedix worth $29.9K as of Q2 2026.
  • IFP Advisors bought 1,056 CorMedix shares in Q2 2026, an estimated $8.34K.
  • CorMedix made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2726 holding.
  • IFP Advisors first reported a position in CorMedix in Q4 2024 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.